Diseases, Conditions, Syndromes

More cost-effective cure for hepatitis C may be close

The cost of treating hepatitis C virus (HCV) could be cut up to 50 percent if mathematical models are used to predict when patients can safely stop taking direct-acting antiviral (DAA) medication, according to a new study ...

Diseases, Conditions, Syndromes

Transplant drug helpful for patients with progressive liver condition

New research indicates that mycophenolate mofetil, a drug that is usually used to prevent rejection after kidney, heart or liver transplant, seems safe and effective in treating autoimmune hepatitis (AIH), a serious chronic ...

Oncology & Cancer

Researchers investigate new ways to tackle bile duct cancer

Experts at the University of Birmingham are working with counterparts at the University of Bristol and in Thailand to identify new ways of detecting and treating a form of bile duct cancer that is claiming more and more lives ...

Diseases, Conditions, Syndromes

Burden, costs of gastrointestinal, liver disease estimated in US

(HealthDay)—In the United States, the burden and associated costs of gastrointestinal (GI), liver, and pancreatic diseases are substantial, according to a report published in the December issue of Gastroenterology.

Diseases, Conditions, Syndromes

Fatty liver disease and scarring have strong genetic component

Researchers at the University of California, San Diego School of Medicine say that hepatic fibrosis, which involves scarring of the liver that can result in dysfunction and, in severe cases, cirrhosis and cancer, may be as ...

Diseases, Conditions, Syndromes

Researchers illuminate key role of NOX proteins in liver disease

Researchers at the University of California, San Diego School of Medicine have demonstrated a direct connection between two signaling proteins and liver fibrosis, a scarring process underlying chronic liver disease, the 12th ...

page 20 from 27